SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-048570
Filing Date
2018-08-01
Accepted
2018-08-01 07:24:19
Documents
18
Period of Report
2018-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18035_18k.htm 8-K 30525
2 EX-99.1 a18-18035_1ex99d1.htm EX-99.1 156241
3 EX-99.2 a18-18035_1ex99d2.htm EX-99.2 21248
4 EX-99.3 a18-18035_1ex99d3.htm EX-99.3 28559
5 GRAPHIC g180351mm01i001.jpg GRAPHIC 3433
6 GRAPHIC g180351moi001.gif GRAPHIC 34386
7 GRAPHIC g180351moi002.gif GRAPHIC 127994
8 GRAPHIC g180351moi003.gif GRAPHIC 80935
9 GRAPHIC g180351moi004.gif GRAPHIC 76640
10 GRAPHIC g180351moi005.gif GRAPHIC 66576
11 GRAPHIC g180351moi006.gif GRAPHIC 79355
12 GRAPHIC g180351moi007.gif GRAPHIC 96613
13 GRAPHIC g180351moi008.gif GRAPHIC 67462
14 GRAPHIC g180351moi009.gif GRAPHIC 44877
15 GRAPHIC g180351moi010.gif GRAPHIC 97782
16 GRAPHIC g180351moi011.gif GRAPHIC 75482
17 GRAPHIC g180351moi012.gif GRAPHIC 19121
18 GRAPHIC g180351mqi001.jpg GRAPHIC 3474
  Complete submission text file 0001104659-18-048570.txt   1442564
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 18983022
SIC: 2834 Pharmaceutical Preparations